Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychotropics in pregnancy: weighing the risks.

Sandeep Grover1, Ajit Avasthi, Yogesh Sharma

  • 1Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh 160012, India.

The Indian Journal of Medical Research
|June 20, 2006
PubMed
Summary

The safety of psychotropic medications during pregnancy remains uncertain. Physicians must weigh the risks of fetal exposure against the dangers of untreated maternal mental illness when prescribing these drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Internalized stigma in patients with severe mental illness (SMI): A cross-sectional study from Northwestern India.

Indian journal of psychiatry·2026
Same author

Age of onset and course and outcome of bipolar disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study).

Indian journal of psychiatry·2025
Same author

A Network Analysis of Psychiatric Symptoms in Patients With Schizophrenia Treated With Antipsychotic Polypharmacy Using Propensity Score Matching: Findings From the Research on Asian Psychotropic Prescription Patterns (REAP) Study.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2025
Same author

Adjunctive Antidepressant Use in Bipolar Disorder and Its Clinical Correlates: An Asian Psychotropic Prescription Patterns Consortium Study.

Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists·2025
Same author

Global psychiatrists' opinions about <i>hikikomori</i> from biopsychosocial perspectives: International case vignette survey.

PCN reports : psychiatry and clinical neurosciences·2025
Same author

Factors associated with lifetime rapid cycling in bipolar disorder: Findings from the Bipolar Disorder Course and Outcome study from India (BiD-CoIN study).

Journal of affective disorders·2025

Area of Science:

  • Psychiatry
  • Pharmacology
  • Reproductive Medicine

Background:

  • Increasing use of newer psychotropic medications raises concerns about potential teratogenicity.
  • Prospective studies on pregnant women are ethically challenging, limiting definitive safety data.
  • Physicians rely on case reports, case series, and retrospective studies for evidence.

Purpose of the Study:

  • To review current evidence on teratogenic risks associated with commonly used psychotropic drugs in pregnancy.
  • To provide guidance on decision-making for prescribing psychotropics to pregnant patients.
  • To highlight the balance between maternal mental health treatment and fetal safety.

Main Methods:

  • Comprehensive literature review of existing studies on psychotropic drug safety in pregnancy.

Related Experiment Videos

  • Analysis of teratogenic risks based on available case reports, case series, and retrospective data.
  • Discussion of clinical decision-making frameworks for managing psychiatric disorders during gestation.

    • Main Results:

    • Evidence on the safety of psychotropic medications in pregnancy is inconclusive.
    • Risk-benefit assessment is crucial, considering both fetal teratogenicity and maternal disorder severity.
    • Untreated maternal psychiatric conditions pose significant risks that may outweigh drug exposure risks.

    Conclusions:

    • The decision to use psychotropic drugs during pregnancy requires careful consideration of individual patient factors.
    • Psychotropic prescribing should be reserved for situations where maternal health benefits clearly outweigh potential fetal risks.
    • Further research is needed to establish definitive safety profiles for psychotropic medications in pregnant populations.